Government of Honduras Reinforces Measures in Response to COVID-19 Outbreak

More than 4200 Tests Entered the Country Biomedical Equipment, Protection Kits and Shelters are Some of the Actions Taken for Infected Patients and Healthcare Providers

As part of the prevention and care measures for current and potential cases of Covid-19, the Government of Honduras brought to the country additional new biomedical equipment for the health care of novel coronavirus patients.

In addition, for the protection of the frontline healthcare workers treating confirmed and suspected cases, the Government distributed more than 10,000 medical kits for hospitals and clinics nationwide.

Honduras issued a country-wide red alert for two weeks on Saturday to contain the spread of the coronavirus in the Central American country.

Yesterday´s afternoon, a first case in San Pedro Sula was confirmed, totaling nine confirmed cases nationwide. All cases have been placed under medical observation and self-quarantine, and the curfew has been extended to San Pedro Sula, Central District, La Ceiba and Choluteca.

The rest of the country remains on alert, with restrictions limiting mobilization and circulation, with the exception of essential activities such as buying supplies and medicines during daylight hours.

President Juan Orlando Hernández urged the population to remain calm and avoid spreading alarming false rumors or speculations. “It is very important to stay at home, be aware of updated information from official sources and follow the prevention advices issued by the Ministry of Health,” said the Honduran president.

President Hernández and other officials have addressed the nation on regular basis on media briefings. The government also opened the site www.covid19honduras.org

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version